This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes

This study is currently recruiting participants.
See Contacts and Locations
Verified June 2017 by Catalyst Pharmaceuticals, Inc.
Sponsor:
Information provided by (Responsible Party):
Catalyst Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT02562066
First received: September 24, 2015
Last updated: June 2, 2017
Last verified: June 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2017
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)